Back to Search
Start Over
The Fast Track FIT study : diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer
- Source :
- The British Journal of General Practice
- Publication Year :
- 2021
-
Abstract
- BackgroundThe faecal immunochemical test (FIT) is now available to support clinicians in the assessment of patients at low risk of colorectal cancer (CRC) and within the bowel cancer screening programme.AimTo determine the diagnostic accuracy of FIT for CRC and clinically significant disease in patients referred as they were judged by their GP to fulfil National Institute for Health and Care Excellence guideline 12 (NG12) criteria for suspected CRC.Design and settingPatients referred from primary care with suspected CRC, meeting NG12 criteria, to 12 secondary care providers in Yorkshire and Humber were asked to complete a FIT before investigation.MethodThe diagnostic accuracy of FIT based on final diagnosis was evaluated using receiver operating characteristics analysis. This permitted a statistically optimal cut-off value for FIT to be determined based on the maximisation of sensitivity and specificity. Clinicians and patients were blinded to the FIT results.ResultsIn total, 5040 patients were fully evaluated and CRC was detected in 151 (3.0%). An optimal cut-off value of 19 µg Hb/g faeces for CRC was determined, giving a sensitivity of 85.4% (95% confidence interval [CI] = 78.8% to 90.6%) and specificity of 85.2% (95% CI = 84.1% to 86.2%). The negative predictive value at this cut-off value was 99.5% (95% CI = 99.2% to 99.7%) and the positive predictive value 15.1% (95% CI = 12.8% to 17.7%). Sensitivity and specificity of FIT for CRC and significant premalignant polyps at this cut-off value were 62.9% (95% CI = 57.5% to 68.0%) and 86.4% (95% CI = 85.4% to 87.4%), respectively; and when including all organic enteric disease were 35.7% (95% CI = 32.9% to 38.5%) and 88.6% (95% CI = 87.5% to 89.6%), respectively.ConclusionFIT used in patients fulfilling NG12 criteria should allow for a more personalised CRC risk assessment. FIT should permit effective, patient-centred decision-making to inform the need for, type, and timing of further investigation.
- Subjects :
- medicine.medical_specialty
Colorectal cancer
Sensitivity and Specificity
03 medical and health sciences
Feces
Hemoglobins
0302 clinical medicine
Internal medicine
Epidemiology
medicine
Humans
Early Detection of Cancer
Receiver operating characteristic
business.industry
Research
Guideline
Colonoscopy
colorectal neoplasms
medicine.disease
Confidence interval
predictive value of tests
030220 oncology & carcinogenesis
Predictive value of tests
Occult Blood
030211 gastroenterology & hepatology
Fast track
Family Practice
business
Risk assessment
Subjects
Details
- Language :
- English
- ISSN :
- 14785242
- Database :
- OpenAIRE
- Journal :
- The British Journal of General Practice
- Accession number :
- edsair.doi.dedup.....354626eb0556f55bf7748041983b5d5a